Emergence agitation
Conditions
Interventions
Nalbuphine Group:A dose of 0.1 mg/kg nalbuphine was administered intravenously 15 to 30 minutes before the end of surgery.
Control Group:An equal volume of normal saline was administered intravenously 15 to 30 minutes before the end of surgery.
Sponsors
SUN YAT-SEN MEMORIAL HOSPITAL
Eligibility
Sex/Gender
All
Age
3 Years to 7 Years
Inclusion criteria
Inclusion criteria: 1.ASA physical status I or II; 2.Scheduled to undergo otolaryngologic surgery; 3.Aged 3 to 7 years;
Exclusion criteria
Exclusion criteria: 1.Patients with attention deficit or hyperactivity disorder; 2.Autism; 3.Neurological disorders; 4.Pre-existing airway abnormalities or reactive airway disease; 5.History of psychotropic medication use or substance abuse within one month prior to surgery; 6.Major organ comorbidity; 7.Intellectual disability or developmental delay; 8.Genetic disorders; 9.Known allergy to nalbuphine;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pediatric Anesthesia Emergence Delirium Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| PACU Length of Stay;Medications used during the PACU stay;Heart rate, oxygen saturation, and blood pressure in the PACU;Postoperative Behavioral Changes;Adverse Events;Extubation Time;Face, Legs, Activity, Cry, Consolability Scale;Emergence Time; | — |
Countries
China
Contacts
Public ContactGanglan Fu
SUN YAT-SEN MEMORIAL HOSPITAL
Outcome results
None listed